Market Tracker

07/01 7:27am ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.2302
Delayed Data
As of Jun 30
 -0.0028 / -1.20%
Today’s Change
0.20
Today|||52-Week Range
0.64
-35.21%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.23
Today’s open0.23
Day’s range0.22 - 0.24
Volume373,037
Average volume (3 months)303,781
Market cap$21.7M
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.97

Competitors

 Today’s
change
Today’s
% change
OPGNOpGen Inc-0.06-3.80%
ABACAoxin Tianli Group I...+0.05+6.41%
HTGMHTG Molecular Diagno...+0.21+8.37%
FSIFlexible Solutions I...-0.06-4.11%
Data as of 06/30/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Principal Financial &
Accounting Officer
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts